跳至主要内容
临床试验/NCT01976754
NCT01976754已完成不适用

The Effective Dose of Dexmedetomidine for Moderate Sedation of Adult Intubated Septic Patients in the ICU.

First Affiliated Hospital of Zhejiang University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Dose of dexmedetomidine

研究概览

简要总结

Septic patients in Intensive Care Unit always need mechanical ventilation and conscious-sedation. But the recommended dose 0.2-0.7μg/kg/h could not run well because of wide range. The purpose of this study is to find the effective dose of dexmedetomidine adult septic patients of mechanical ventilation .

详细描述

Inclusion Criteria:

Age: between 18 years mechanical ventilation RASS≥2 A diagnosis of sepsis within 48 hours

Exclusion Criteria:

Cardiac disease Cardiac rhythm abnormalities liver dysfunction coma severe hypotension muscle relaxant users

Primary Outcome Measures:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • intubated patients RASS≥2 A diagnosis of sepsis within 48h

排除标准

  • Cardiac disease Cardiac rhythm abnormalities liver dysfunction coma severe hypotension muscle relaxant users

研究组 & 干预措施

dexmedetomidine,sepsis,ED50

Other

Intervention Name: dexmedetomidine dosage form: intravenous injection dosage:0.2-0.7μg/kg/h frequency: 1 duration:12 hours

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Dose of dexmedetomidine

时间窗: 12 hours

次要结局

  • RASS score Requirement for rescue intervention, RASS will be recorded per hour.(1 hour)

研究者

发起方
First Affiliated Hospital of Zhejiang University
申办方类型
Other
责任方
Principal Investigator
主要研究者

zhanqin zhang

PHD candidate

First Affiliated Hospital of Zhejiang University

研究点 (1)

Loading locations...

相似试验